---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-26-000229"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2026-09-24T20:31:17+00:00"
generated_at: "2026-09-24T20:32:11.442736+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Clover Health appoints former Sen. Robert Torricelli and Dr. Brian Miller to board

## Summary
- Senator Robert Torricelli appointed Class I director, Dr. Brian J. Miller Class III director, effective September 22, 2026.
- Torricelli joins Audit Committee; Miller joins Clinical Committee; board now nine directors, filling two vacancies.
- Each receives pro rata 2026 director retainer and $200,000 RSU prorated for service days through Dec 31, 2026.
- Torricelli is former U.S. Senator (NJ) and Clover insurance subsidiary board member since 2022; Miller is MedPAC commissioner and Johns Hopkins hospitalist.

## SEC filing metadata
- accession: 0001801170-26-000229
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2026-09-24T20:31:17+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000229/0001801170-26-000229-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000229/clov-20260922.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-26-000229
- JSON: https://secwatch.observer/filing/0001801170-26-000229.json
- Plain text: https://secwatch.observer/filing/0001801170-26-000229.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.